Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 234

1.

[Clinical practice guidelines for the management of dyslipidemia in chronic kidney disease].

Shoji T.

Nihon Jinzo Gakkai Shi. 2013;55(7):1267-75. Review. Japanese. No abstract available.

PMID:
24288962
2.

[Effect of statins on renal function].

Kasahara M.

Nihon Jinzo Gakkai Shi. 2013;55(7):1295-300. Review. Japanese. No abstract available.

PMID:
24288966
3.

[Clinical significance of treatment for dyslipidemia in CKD].

Ikemori A, Kimura K.

Nihon Jinzo Gakkai Shi. 2013;55(7):1287-94. Review. Japanese. No abstract available.

PMID:
24288965
4.

Drug insight: the role of statins in combination with ezetimibe to lower LDL cholesterol.

Gotto AM Jr, Farmer JA.

Nat Clin Pract Cardiovasc Med. 2006 Dec;3(12):664-72. Review.

PMID:
17122799
5.

Effect of statins on cardiovascular events in patients with mild to moderate chronic kidney disease: a systematic review and meta-analysis of randomized clinical trials.

Zhang X, Xiang C, Zhou YH, Jiang A, Qin YY, He J.

BMC Cardiovasc Disord. 2014 Feb 17;14:19. doi: 10.1186/1471-2261-14-19. Review.

6.

Is lipid management effective for all stages of CKD?.

Ku E, Campese V.

Blood Purif. 2013;35(1-3):26-30. doi: 10.1159/000345932. Epub 2013 Jan 22. Review.

7.

[Are therapeutic LDL goals justified? Controversies between the European and American guidelines].

Bertomeu-Martínez V.

Medwave. 2016 Dec 30;16(Suppl4):e6825. doi: 10.5867/medwave.2016.6825. Review. Spanish.

PMID:
28055995
8.

[Target levels for LDL cholesterol are put out of the running. Cholesterol should be lowered maximally in high cardiovascular risk].

Olsson AG.

Lakartidningen. 2011 Jun 1-14;108(22-23):1240-3. Review. Swedish. No abstract available.

PMID:
21786498
9.

High cardiovascular risk in patients with diabetes and the cardiometabolic syndrome: mandate for statin therapy.

Gonzalez GL, Manrique CM, Sowers JR.

J Cardiometab Syndr. 2006 Summer;1(3):178-83. Review.

10.

Role of dyslipidemia in patients with chronic kidney disease.

Marino A, Tannock LR.

Postgrad Med. 2013 Jul;125(4):28-37. doi: 10.3810/pgm.2013.07.2676. Epub 2013 Jul 10. Review. No abstract available.

PMID:
23842535
11.

Management of dyslipidemias in patients with diabetes and chronic kidney disease.

Molitch ME.

Clin J Am Soc Nephrol. 2006 Sep;1(5):1090-9. Epub 2006 Jul 26. Review.

12.

Lipid management in chronic kidney disease: synopsis of the Kidney Disease: Improving Global Outcomes 2013 clinical practice guideline.

Tonelli M, Wanner C; Kidney Disease: Improving Global Outcomes Lipid Guideline Development Work Group Members.

Ann Intern Med. 2014 Feb 4;160(3):182. doi: 10.7326/M13-2453.

PMID:
24323134
13.

[The discussion on target goals in lipid reduction is still going on. The Expert Committee--a block for current cardiovascular prevention].

Olsson AG.

Lakartidningen. 2011 Nov 23-29;108(47):2442-3. Swedish. No abstract available.

PMID:
22468387
14.

Are we lowering LDL cholesterol sufficiently?

Barter P, Rye KA.

Nat Clin Pract Cardiovasc Med. 2006 Jun;3(6):290-1. No abstract available.

PMID:
16728988
15.

[Epidemiology of dyslipidemia in CKD].

Iseki K.

Nihon Jinzo Gakkai Shi. 2013;55(7):1263-6. Japanese. No abstract available.

PMID:
24288961
16.

Should we use statins in all patients with chronic kidney disease without dialysis therapy? The current state of knowledge.

Rysz J, Gluba-Brzózka A, Banach M, Więcek A.

Int Urol Nephrol. 2015 May;47(5):805-13. doi: 10.1007/s11255-015-0937-9. Epub 2015 Mar 11. Review.

PMID:
25758011
17.

Efficacy and safety of rosuvastatin in the management of dyslipidemia.

Rubba P, Marotta G, Gentile M.

Vasc Health Risk Manag. 2009;5(1):343-52. Epub 2009 Apr 8. Review.

18.

[Lipid-lowering cardiovascular prevention in type 2-diabetes. Statins are effective according to the FIELD study].

Båvenholm P, Attvall S, Nilsson PM.

Lakartidningen. 2006 Aug 30-Sep 5;103(35):2462-6. Review. Swedish. No abstract available.

PMID:
17002161
19.

[Chronic renal insufficiency and cardiovascular disease].

Charriere S, Rognant N, Chiche F, Cremer A, Deray G, Priou M.

Ann Cardiol Angeiol (Paris). 2009 Feb;58(1):40-52. doi: 10.1016/j.ancard.2008.07.010. Epub 2008 Aug 19. Review. French.

PMID:
18937921
20.

[Dyslipidemia and the risk of kidney disease].

Ligabue G, Cavazzini F, Albertazzi A.

G Ital Nefrol. 2007 Sep-Oct;24 Suppl 38:8-12. Italian.

PMID:
17922441

Supplemental Content

Support Center